News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Measurable residual disease monitoring in AML
Oct 1, 2024, 15:57

Measurable residual disease monitoring in AML

Top Biomedical Science shared on X:

“Measurable residual disease monitoring in AML:

Prospects for therapeutic decision-making and new drug development.”

Source: Top Biomedical Science/X

Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug development

Authors: Nicholas J. Short, Richard Dillon

disease

AML cancer drug development leukaemia Nicholas J. Short OncoDaily Oncology residual disease monitoring Richard Dillon Top Biomedical Science
Special Coverage
Insight
Nov 15, 2024, 02:40
Patrick Hwu was Named one of the 2024 Florida 500 for Leadership in Medicine and Cancer Research
Blog
Nov 14, 2024, 17:57
European Cancer Organisation's Memorandum of Understanding with UNFPA
Blog
Nov 14, 2024, 17:51
Research is for everyone. Every voice and experience matters - Young Lung Cancer Initiative
Blog
Nov 14, 2024, 17:48
Marco Donia: Pleased to be Co-chairing with Timothée Olivier in an educational session at ESMOImmuno24
Blog
Nov 14, 2024, 17:46
Dinesh Pendharkar: Continuing mission of Sickle cell disease and Cancer
Blog
Nov 14, 2024, 17:46
Abstracts submissions open for MASCC25
Blog
Nov 14, 2024, 17:42
Shahana Banerjee: Reimagining Healthcare with Sachin H. Jain
Blog
Nov 14, 2024, 17:32
Nandita Kotwani: KidsX collaboration with the CancerX Moonshot 2025 Accelerator program
Blog
Nov 14, 2024, 17:23
Douglas Flora: UK Markey Cancer Center Affiliate Network 2024 Cancer Care Conference
Blog
Nov 14, 2024, 17:19
Cate OReilly: Sally Werner on the transformative impact of supportive cancer care
Blog
Nov 14, 2024, 17:14
Petra Ibum Adjah: Men's Health Matter
Blog
Nov 14, 2024, 16:54
Roupen Odabashian: Looking for medical students or residents interested in conducting AI research in oncology